Thomas Jefferson University Hopsital — Philadelphia, Pennsylvania

Thomas Jefferson University Hopsital is a clinical research site located in Philadelphia, Pennsylvania, United States 19017.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University Hopsital has participated in 4 clinical trials.

Therapeutic areas: Newborn Jaundice, Breast Carcinoma, Caregiver.

Sponsors: BiliCam, LLC, Thomas Jefferson University.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University Hopsital?

Thomas Jefferson University Hopsital has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University Hopsital conducted?

Thomas Jefferson University Hopsital has 4 clinical trials on record. Their work covers Newborn Jaundice, Breast Carcinoma, Caregiver.

Is Thomas Jefferson University Hopsital accredited by Crixeo Health?

Thomas Jefferson University Hopsital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University Hopsital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.